Charting New Territories in the Management of Individuals with Immune-Mediated Inflammatory Disease and Obesity: Calming Concomitant Pathologies

flourish logo

Wednesday, May 27, 2026

6:30 PM – 8:00 PM PT
7:30 PM – 9:00 PM MT
8:30 PM – 10:00 PM CT
9:30 PM – 11:00 PM ET

Program Highlights

  • 1.5 CME & CNE Credit
  • Interactive case-based discussion
  • Real patient cases from Day in the Life docuseries
  • Whiteboard animations
  • A variety of point-of-care tools & resources
  • Patient advocacy resource station

Program Overview

This gastroenterology-focused CME summit uses interactive, case-based discussions to examine the shared inflammatory messengers that link obesity with inflammatory bowel disease (IBD) and contribute to both intestinal and systemic pathology. Faculty will guide participants in applying current obesity treatment guideline recommendations and supporting evidence to real-world IBD scenarios involving patients with excess body weight. Through collaborative problem solving and multidisciplinary dialogue, attendees will explore practical strategies to build and sustain coordinated care teams that optimize outcomes for patients navigating both IBD and obesity.

Target Audience

This educational activity is intended to educate rheumatologists, gastroenterologists, dermatologists, and related advanced practice providers in the care of patients with obesity and IMIDs.

Learning Objectives

Upon the completion of this program, attendees should be able to:

  • Describe the immune messengers common to both obesity and IMIDs and their resultant corresponding pathologies
  • Incorporate obesity treatment guideline recommendations and their supporting data into the management of patients with both IMIDs and excess body weight
  • Develop and maintain a collaborative multidisciplinary team to optimize care for the patient with IMIDs and obesity

Joint Accreditation Statement

Joint Accreditation Statement

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Credit Designation Statement

Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

ACCME Innovation Partner

Nurses (ANCC) Credit Designation

Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.

Disclosure Policy Statement

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group (MLG) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Disclosure of Relevant Financial Relationships

Faculty Member Disclosures
Stephanie L. Gold, MD Has nothing to disclose
Elizabeth A. Spencer, MD, MS Fees for Non-CME/CE Services: Advisory board for Celltrion

All relevant financial relationships have been mitigated.

Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.

Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
Matthew Frese, MBA, General Manager for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
Chris Drury, MA, MS, MBA, Medical Director for Med Learning Group, has nothing to disclose.
A medical reviewer from CME Peer Review LLC, has nothing to disclose.
Abigail Dill, Program Manager for Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.

Disclosure Of Unlabeled Use

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

Method of Participation

There are no fees for participating and receiving CE credit for this activity.

In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.

Your certificate will be provided as a downloadable file.

Disclaimer

Med Learning Group makes every effort to develop CE activities that are science based.

This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her/their clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

ACCME Innovation Partner Disclaimer

Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.

Med Learning Group

This activity is provided by Med Learning Group.

This activity is supported by an educational grant from Lilly.

Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Release date: May 27, 2026
Expiration date: May 27, 2026
Estimated time to completion: 1.5 hours